Project Grant HT94252411071
Award Date
11/1/24
Completion Date
10/31/28
Dollars Obligated
$2.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $780,000.00 to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to support research on "An Unconventional Pathway to Melanoma Development and Prevention". The research aims to investigate innovative approaches to address melanoma, a serious form of skin cancer, with the goal of improving...
The Defense Health Agency awarded a $1,260,839 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The grant, effective May 1, 2025 through April 30, 2029, will support research targeting EHMT1/2 to overcome therapy-resistant ovarian cancer. As a prominent public research university, the University of Colorado-Denver leverages its expertise across multiple...
This federal Project Grant award in the amount of $624,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Colorado-Denver. The grant will fund a 2-year project from July 1, 2024 to June 30, 2026 to investigate the use of cell-free DNA to define MYC activity in osteosarcoma. The University of Colorado-Denver, a major public research institution, will serve as the primary awardee and perform the research...
The University of Colorado Denver was awarded a $3,067,768 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to investigate the mechanisms underlying brain metastatic progression in ER+ breast cancer. The three-year award running from September 1, 2022 to August 31, 2025 will support research into medical solutions for the battlefield by transforming healthcare through innovative and impactful...
The University of Colorado-Denver has been awarded a $1,130,984 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "DEFINING AND TARGETING CHROMOBOX2 (CBX2)-MEDIATED CHEMORESISTANCE IN HIGH GRADE SEROUS CARCINOMA". The grant will support the university's research efforts to investigate novel approaches for overcoming chemoresistance in high-grade serous carcinoma, a form of ovarian cancer, over a...
This $2,131,064 federal Project Grant awarded by the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the University of Colorado-Denver supports research on the effects of androgen receptors in luminal breast cancer. The four-year project, titled "ANDROGEN RECEPTORS IN LUMINAL BREAST CANCER: EFFECTS ON RESPONSE TO ENDOCRINE THERAPY AND AN IMMUNE-SUPPRESSIVE TUMOR IMMUNE MICROENVIRONMENT (TIME)", aims to investigate how androgen receptor...
The federal Project Grant award in the amount of $999,793.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). This award is supporting research by the Regents of the University of Colorado, specifically the University of Colorado Office of Contracts and Grants Division, to conduct targeted suppression of rodent models for multiple sclerosis (MS). The grant aims to deliver fundamental research and develop specialized data...
The U.S. Department of the Army Medical Command awarded a $1,363,999 project grant under the Military Medical Research and Development (CFDA 12.420) program to the University of Colorado-Denver. The grant, titled "Living Well with Brain Cancer (LWBC): A Group-Based Intervention to Promote Whole-Person Well-Being," will fund research to develop and evaluate a group-based intervention to improve the overall well-being of individuals living with brain cancer. The University of...
The federal Project Grant award of $1,225,783 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a fully automated deep learning-based framework for segmentation and treatment response assessment of lesions on PSMA PET/CT in prostate cancer. This research, conducted by the University of Colorado-Denver, aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $577,680.00 to The Regents of the University of Colorado to conduct research aimed at "TARGETING EHMT1/2 TO OVERCOME THERAPY-RESISTANT OVARIAN CANCER". The research, to be performed at the University of Colorado in Boulder, CO, seeks to develop innovative medical solutions to transform healthcare for military service members, veterans, and the...